Investorideas.com - Cannabis Stocks see Continued Expansion Progress, and Retail Opportunities in Nevada; New M (OTC: $GOHE) (OTCQX: $TRTC) (TSXV: $NRTH,V) (OTC: $NCNNF), (CSE: $TGIF.C) (OTC: $TGIFF)
Get the latest Cannabis and Hemp stock news from www.investorideas.com
Tuesday 27 August 2019
Monday 26 August 2019
Investorideas.com - Stiiizy Unveils Flagship Store in Downtown Los Angeles Grand Opening
Investorideas.com - Stiiizy Unveils Flagship Store in Downtown Los Angeles Grand Opening
www.investorideas.com - news that inspires big ideas
www.investorideas.com - news that inspires big ideas
Snapshot looking at #Cannabis #Stocks in #Nevada: #Payment #Tech Solutions to #Retail Deals (OTC: $GOHE), (OTCQX: $TRTC), (TSXV: $NRTH.V) (OTC: $NCNNF), (CSE: $TGIF.C) (OTC: $TGIFF)
Snapshot looking at #Cannabis
#Stocks in #Nevada: #Payment #Tech Solutions to #Retail Deals (OTC: $GOHE),
(OTCQX: $TRTC), (TSXV: $NRTH.V) (OTC: $NCNNF), (CSE: $TGIF.C) (OTC: $TGIFF)
Point Roberts WA,
Delta, BC –August 26, 2019 - Investorideas.com, a leading investor
news resource covering hemp and cannabis stocks releases a snapshot focusing on
the recent developments occurring in the Nevada cannabis market as it matures
and expands.
A recent news report discussing the
potential of the Nevada market versus the California market mentioned, “a more
intriguing metric offered in State of the
Legal Cannabis Markets -- spending per capita -- suggesting that another
state could blow California out of the water in terms of attractiveness to
businesses and investors: Nevada.”
The article
continued, “Between 2018 and 2024, Arcview and BDS are forecasting that
Nevada's population will increase by about 10% to 3.4 million. Yet, with the
Silver State opening its doors to recreational marijuana sales in July 2017,
total legal spending is expected to surge from $567 million in 2018 to $1.41
billion by 2024. On a per-capita basis, this works out to $415.57 in spending.
That's more than double California ($172.08), and is higher than every other
state in the country. It's no secret that Nevada's exceptionally high spending
per capita forecast stems from the state's strong tourism. Las Vegas is a core
attraction for Americans and visitors from all over the world, which should
allow cannabis companies to focus their attention on Sin City to drive sales
and margins. Plus, Nevadans are faced with a combined 25% tax rate, including a
15% tax on wholesale sales, and 10% on retail sales. That's significantly less
than neighboring California, which should help reduce illicit production.”
Assuming Arcview's
and BDS Analytics' projections prove relatively accurate, there are a number of ways to play the most
lucrative market in the United States.
Global Payout Inc. (OTC: GOHE), through its Nevada
based subsidiary MTrac Tech Corporation, provides electronic wallet and e-banking financial
solutions for the marijuana industry, recently announced that the company has retained one of the nation’s leading government
affairs organizations, Strategies 360, to further the platform’s legislative
push to be recognized as the most innovative and seamless SaaS (Software as a
Service) solution to facilitate cashless, compliant, and secure payments for
the legalized cannabis industry.
Headquartered in
Seattle, WA, S360 represents a broad range of sectors with an expanding
footprint in 12 western states and DC. The S360 team is comprised of some of
the brightest, forward-thinking former executives from various industries, such
as technology, finance and energy, in addition to former state public office
holders.
Read this in full at https://www.investorideas.com/news/2019/cannabis/08261Nevada-PaymentTech.asp
One of the primary
goals of the MTrac platform has been to assist governments in their efforts to
both regulate the cannabis industry and solve the issues associated with cash
heavy transactions and a lack of available banking resources. Some states have
recently been exploring closed-loop systems to implement statewide regulatory
oversight of legal cannabis operations. For example, the state of Arizona has
opened a “Fintech” sandbox, allowing various closed-loop systems into the
Arizona market on a limited basis to see how well they operate. Nevada will
very shortly, be opening a Request for Proposal to find a closed-loop,
blockchain platform that will allow their cannabis industry to accept digital
payments. It is the opinion of management that the MTrac system is the most
seamless version of this payment platform available and offers the added
benefit of having a large and growing customer base to provide proof of
concept, similar to the recent state-wide launch in Louisiana.
“The agreement with
S360 could not have been timelier in terms of presenting our solution to the
western region, to showcase the features and functionality of the platform’s
closed-loop eWallet accounts for the states’ lawmakers.” said Mr. Jason
LeBlanc, Chief Compliance Officer of MTrac. “We are extremely excited to be
working with such a dynamic and results-driven government affairs team. The
opportunity to present our platform at the highest levels of state regulators
and legislators is an objective that our legal and compliance teams have been
working toward for the last several months, and the partnership with S360 is
now making this opportunity a reality.”
The Company looks
forward to working closely with the S360 team to introduce its payment platform
to the western states and will keep shareholders apprised of its progress at
regular intervals.
Terra Tech Corp. (OTCQX:TRTC), a vertically
integrated cannabis-focused agriculture company, recently announced that it has entered
into an agreement to sell 100% of the assets of its Blüm Reno dispensary,
located at 1085 S Virginia St. Suite A, Reno, NV 89502, including the building
where the dispensary is located, for a purchase price of $15,000,000.
Terra Tech’s Blüm
Reno dispensary has been operational since January 2017 and provides cannabis
products to the local medical and adult-use markets, including the Company’s
proprietary IVXX™ brand of premium medical cannabis, flowers, shatters, waxes
and oils, among other high-quality cannabis products from a range of reputable
providers of superior grade medical cannabis.
Derek Peterson, CEO
of Terra Tech, commented, ''Selling the cannabis retail license for our Blüm
Reno dispensary is another key milestone in our restructuring plan, a strategy
that has been implemented to leverage our balance sheet to fuel growth, as
opposed to approaching the capital markets more often than is necessary. Our
Blüm dispensary in Reno has substantially increased in value since its opening,
and selling its assets allows the Company to strategically monetize this asset.
To move forward with our restructuring strategy, we plan to redeploy the
additional capital generated by this sale toward more productive assets in
California in areas such as infrastructure and sales and marketing.”
Terra Tech
anticipates the closing of the transaction within 90 days, pending all state
and local jurisdictional approvals.
The Nevada market is
also starting to attract more Canadian companies such as 48North Cannabis Corp. (TSXV: NRTH) (OTC: NCNNF), who is hoping to
enter into the Nevada market soon, as the company recently signed a definitive
agreement to acquire Rare Industries, Inc., also known as Quill, a vape
technology brand.
Quill’s products are
being distributed in Oregon and Washington, with plans to reach California and
Nevada. The company said this acquisition is its first attempt to reach the US.
"48North
recognizes the importance of entering the burgeoning US market. I believe that
authentic brands and next-generation products distributed at scale,
particularly in the emerging US market, will be one of the major keys to
success in the cannabis industry," Alison Gordon, co-CEO of 48North said
in a statement. "Without question, the Quill suite of products aligns
closely with 48North's growing portfolio of brands.”
The total purchase
price was set to $2.1 million out of which $641,000 is cash and $1.46 million
is in the form of 48North’s common shares at a price of around 86 cents per
share, the company reported.
48North plans to
utilize Quill’s distribution network to promote its portfolio of brands in the
US, and also to sell Quill’s products via its distribution networks in Canada.
"48North's
industry-leading focus on next-generation cannabis products and its brand-first
consumer strategy will undoubtedly elevate Quill, its brand and products to the
next-level. The US-based Quill team is eagerly looking forward to joining with
48North's experienced and dedicated management team," said Ian Van Vaughan
Shaughnessy, co-founder of Quill.
1933
Industries Inc. (CSE: TGIF) (OTC: TGIFF), a vertically integrated cannabis consumer packaged
goods company, recently commenced the transfer
of cannabis plants to its new cultivation facility in Las Vegas following an
extensive period of systems-wide testing.
"This is a brand
new facility and we worked around the clock to ensure that all systems were
operational before transferring our plants,'' commented Mr. Tim Spencer,
Director of Cultivation. The new facility allows the Company to cultivate five
times the amount of cannabis flower that was previously produced to meet the
high demand for its branded flower and concentrate products under the
Alternative Medicine Association (AMA) line, which are sold in licensed
dispensaries in Nevada. AMA also produces well-known brands such as Gotti's
Gold, Kurupt's Moonrocks, and Denver Dab Co. under licensing agreements. The
increased flower production in the new facility will meet growing demand for
premium cannabis products and will have a significant impact on the Company's
bottom line.
The Company will
welcome OG DNA Genetics (DNA), a globally recognized leader in the research and
development of cannabis genetics, to its new facility. DNA selected AMA as its
partner in Nevada due to the Company's advanced facility, extensive
distribution channels and high-quality standards. DNA will provide specific
expertise to AMA for the development of a consistent phenotype strain for a new
line of co-branded flower and pre-rolls.
"We have
constructed a one-of-a-kind, purpose-built facility, integrated with the latest
technology to increase yields, bolster plant health and assure the consistency
and quality of our products,'' said Mr. Chris Rebentisch, CEO of 1933
Industries Inc. "As experienced cultivators, we understand that
controlling the growing environment is the most important part of cultivating
high-quality craft cannabis at scale, which is why we spent significant time,
capital and management's time, to build a state-of-the-art indoor facility. We
are investing in assets that will provide a continuous supply of the raw
materials necessary to produce our premium cannabis products and improve our
margins.”
In order to verify
that the plants are receiving exact amounts of nutrients and moisture content,
the facility was outfitted with drip automation in order to standardize
cultivation techniques and implement efficient watering and feeding systems
with waste reduction in mind. "We can exactly measure the water and air
content, meaning we are driving each plant's growth with actual data instead of
subjective opinion. This level of refinement is further testament to our
commitment to consistent quality," added Mr. Spencer.
Once the cannabis
plants are situated in the new facility, they will vegetate for approximately
four weeks before the flower cycle is begun for another eight weeks. The next
steps include harvesting, drying, packaging and third-party testing. The entire
cycle takes approximately 16 weeks.
As the Nevada market
expands in population and as more cannabis related infrastructure develops we
can expect it to become a rival, if not overbearing market in comparison to the
already massive California market. State tax and regulation changes could also
play an important role moving forward as federal legalization remains out of
reach in the US.
For investors
following cannabis stocks, Investor Ideas has created a stock directory of publicly
traded CSE, TSX, TSXV, OTC, NASDAQ, NYSE, ASX Marijuana/Hemp Stocks
About
Investorideas.com - News that Inspires Big Investing Ideas
Investorideas.com is a recognized news source
publishing third party news and press releases plus we create original
financial content. Learn about investing in stocks and sector trends
from Investorideas.com with our news alerts , articles , podcasts and
videos talking about cannabis, crypto,
technology including AI and IoT ,
mining ,sports biotech, water, renewable energy and more . Investorideas.com
original branded content includes the daily Crypto Corner and
Podcast, Play
by Play sports and stock news column, Investor Ideas
#Potcasts #Cannabis News and Stocks on the Move podcast and
column, Cleantech and Climate Change
Podcast and the AI
Eye Podcast and column covering developments in
AI.
Follow us on Cannabis Social Media
Disclaimer/Disclosure
Our site does not make
recommendations for purchases or sale of stocks, services or products. Nothing
on our sites should be construed as an offer or solicitation to buy or sell
products or securities. All investing involves risk and possible losses. This site
is currently compensated for news publication and distribution, social media
and marketing, content creation and more. Disclosure is posted for each
compensated news release, content published /created if required but otherwise
the news was not compensated for and was published for the sole interest of our
readers and followers. Contact management and IR of each company directly
regarding specific questions. Disclosure: this news article featuring GOHE is a paid for news release
on Investorideas.com – third party (two thousand) More
disclaimer info: https://www.investorideas.com/About/Disclaimer.asp Learn
more about publishing your news release and our other news services on the
Investorideas.com newswire https://www.investorideas.com/News-Upload/ and tickertagstocknews.com
Global investors must adhere to
regulations of each country. Please read Investorideas.com privacy policy: https://www.investorideas.com/About/Private_Policy.asp
Contact Investorideas.com
800-665-0411
Get more Marijuana,
hemp & cannabis stock investor ideas-
news, articles, podcasts and stock directories
Friday 23 August 2019
Investorideas.com - Timeless (TSXV: TLC.P) Enters into Definitive Agreement for Qualifying Transaction with CannaVerde
Investorideas.com - Timeless (TSXV: TLC.P) Enters into Definitive Agreement for Qualifying Transaction with CannaVerde
Get the latest Cannabis and Hemp stock news from www.investorideas.com
Get the latest Cannabis and Hemp stock news from www.investorideas.com
Investor Ideas #Potcasts; #Cannabis News and #Stocks on the Move: (TSXV: $KHRN.V) (TSX: $AVCN.CA) (TSXV: $NRTH.V) (OTC: $KALY)
Investor Ideas #Potcasts; #Cannabis News and #Stocks on the Move: (TSXV:
$KHRN.V) (TSX: $AVCN.CA) (TSXV: $NRTH.V) (OTC: $KALY)
Delta, Kelowna, BC –August 23, 2019 (Investorideas.com
Newswire) www.Investorideas.com, a global news source covering leading sectors
including marijuana and hemp stocks and its potcast site, www.potcasts.ca release today’s edition of Investorideas.com potcastsCM -
cannabis news and stocks to watch plus insight from thought leaders and
experts.
Listen to the podcast:
Read this in full
at https://www.investorideas.com/news/2019/cannabis-potcasts/08231KHRN-AVCN-NRTH-KALY.asp
Good afternoon and welcome to another episode of
Investorideas.com "Potcast" featuring cannabis news, stocks to watch
as well as insights from thought leaders and experts.
In
today’s podcast we look at a few early announcements.
But
first, Geocann announced that the company has successfully
commercialized the first CBG soft gel products that utilize the multi-patented
VESIsorb® delivery system for optimal absorption and measured
bioavailability. The initial step is utilizing proprietary extraction
technology to isolate and concentrate the CBG that allows Geocann to use its
technical formulation expertise to address the active ingredient’s performance
as it relates to dissolution, absorption, and bioavailability.
The
first of two formulations is a combination of CBG and cannabidiol (CBD) while
the second is a mono-CBG formulation. Both products include strategic
inclusions of beta-caryophyllene (BCP) which has been shown to have synergistic
effects as agonists for the CB2, 5-HT1A and glycine receptors.
“These
product launches further advance Geocann’s leadership position as product
development specialists that provide science-backed solutions to the industry’s
formulation challenges,” said Marc Weder, Chief Scientific Officer. “The
marketplace is demanding advancements beyond just CBD products and we are supremely
positioned to deliver these solutions with more than three decades of research
and product development expertise.”
Weder
states that while the interest is high to include CBG (and other emerging
cannabinoids and terpenes) in new formulations, the poor solubility and
dissolution must be addressed to provide superior product solutions with the
optimized absorption, bioavailability, and maximum therapeutic benefits
consumers are seeking.
“Geocann
has accomplished these results and has successfully transferred a rigorous
product development protocol to the large-scale commercial production of soft
gel capsules, topicals, foods, beverages, and sublinguals that combine these
active ingredients with the VESIsorb® technology,” said Weder.
Geocann
has worldwide exclusivity for cannabinoids formulated with VESIsorb®,
and the company is quickly partnering with strategic brand leaders in key
channels of distribution to deliver its robust portfolio of patent-protected
products.
“The
combination of CBD, CBG, and BCP powered by VESIsorb® in an elegant
soft gel capsule is an important industry milestone,” said Jesse Lopez, CEO and
founder. “Geocann will continue to pioneer the advancement of new cannabinoids,
like CBG, CBN, and THCV, as it’s a privilege to offer these first-to-market
opportunities to our brand partners.”
Khiron Life Sciences Corp. (TSXV: KHRN)
(OTCQB: KHRNF) provided an update on its cultivation and production
operations near Ibague, Colombia, where it has achieved significantly expanded
analysis, extraction and purification capabilities across its cultivation
facility.
Khiron
currently owns and operates one of the most sophisticated medical cannabis
cultivation and processing facilities in Latin America. Building on the
completion of the facility announced on June 2, 2019, the state-of-the-art,
14,000 square foot GMP and ISO 17025 compliant lab now includes full
capabilities in the following:
●
Ultra
high and High performance liquid chromatography ("UHPLC & HPLC")
technology, gas chromatography technology, microbiology testing, and heavy
metals for testing flower and extract samples –Through the use of these
in-house techniques, Khiron can quickly and accurately analyze samples,
identify active cannabis components, and ensure that the products are extracted
and purified to meet local regulations on THC and CBD concentrations.
●
Stability
testing – Stability tests provide evidence on how cannabis products vary over a
given time period and under the influence of environmental factors. Khiron
currently has robust stability testing capacities in place, with studies
designed to evaluate and ensure the quality, safety and efficacy of its products,
across various stages of extraction, as well as final product. In Colombia, stability data is needed to
receive quotas for the production and domestic commercialization of THC
extracts. As part of the Company's commitment to high quality standards,
stability testing for extracts and final products are necessary before shipping
product to consumers.
●
Vertical
integration – Leveraging the Company's cultivation, extraction and purification
capabilities, Khiron has the ability to manage all stages of cannabis
production, from soil to flower to extract, entirely within its own
facility. Its vertically integrated
capabilities serve to maximize efficiency and reliability across the cannabis
supply chain, allowing the Company to streamline operations as it moves towards
the sale and distribution of its products.
Alvaro
Torres, Khiron CEO and Director, stated, "With advanced analysis,
extraction and purification capabilities in place, the company has
performed the analytical and stability
tests required by the authorities to launch medical products and we remain on
track for full commercialization of the grow site, anticipated in Q3 2019. Our
significant investment in the Company's Ibague facility, primarily to target a
market of 6 million patients in Colombia, ensures Khiron remains focused on its
core strategy to serve the domestic market in Latin America."
Through
scalable and flexible operations, the Company has designed its cultivation
capabilities to work within the most up-to-date country quota to meet domestic
demand, including to serve more than 119,000 patients at the Company's IILANS
clinics. Based on the total allocation to the country, the Government of
Colombia allocates annual quotas reflecting the operational plan and production
estimates as outlined in the licence submissions, with the ability to request
additional capacity to meet market demands. Country production quotas for 2020
will be announced by the INCB in January 2020.
Avicanna Inc. (TSX: AVCN) a
biopharmaceutical company focused on the development, manufacturing and
commercialization of plant-derived cannabinoid-based products announced that its
subsidiary, Santa Marta Golden Hemp S.A.S., has completed its first export of
purified CBD from Colombia to Canada for research and development purposes.
Aras Azadian, Chief Executive Officer of Avicanna
commented "We are thrilled to complete our first export and proud to be
doing so into Canada. This is another validation of Avicanna's ability to
execute on all of its verticals and demonstrates the success and advantage of
Avicanna's cultivation infrastructure, extraction and purification capacity,
and regulatory expertise."
Health Canada issued three authorizations to SMGH on June
28, 2019 to allow for the import of CBD isolates and cannabis resin into Canada
from Colombia for scientific purposes. The CBD isolates cleared Colombian
border procedures and were exported from Colombia on August 22, 2019.
48North Cannabis Corp. (TSXV:NRTH) announced that
it has entered into a definitive agreement dated August 22, 2019 to acquire
Rare Industries, Inc. ("Quill"),
a U.S. multi-state Vape Technology brand with product distribution in Oregon
and Washington and near-term expansion plans for California and Nevada. The
acquisition marks 48North's first foray into the United States.
Quill, a leader in the manufacturing of
beautifully designed, lifestyle-focused and sleek vape products, specializes in
the development of easy-to-use, controlled-dosage and health-focused disposable
vape pens.
Quill distributes its unfinished branded
proprietary vape delivery hardware to licensed cannabis processors who finish
the products (including by filling the hardware with cannabis extracts) and
distribute the finished products to licensed cannabis retailers. Quill is not
itself engaged in the cultivation, distribution or possession of cannabis in
the United States.
This year, in addition to Quill's
established products, the company is launching a full-spectrum, hemp based,
CBD-specific, internationally distributed, all-in-one vaporizer pen. As a
result, 48North-owned products will now have multi-state distribution and the
ability to be licensed globally, where legally permitted.
"48North recognizes the importance
of entering the burgeoning U.S market. I believe that authentic brands and
next-generation products distributed at scale, particularly in the emerging
U.S. market, will be one of the major keys to success in the cannabis
industry," said Alison Gordon, co-CEO of 48North.
"Without question, the Quill suite
of products aligns closely with 48North's growing portfolio of brands. This
acquisition marks a critical step in the Company's goal to become the trusted
leader in the development, manufacturing and distribution of next-generation
cannabis products and brands," Ms. Gordon continued.
48North intends to leverage Quill's
expanding distribution network to accelerate the distribution of the Company's
brand portfolio into the United States. 48North also intends to pursue
opportunities to sell Quill products throughout its existing distribution
network in Canada.
Kali-Extracts, Inc. (OTC:
KALY) published
a new website dedicated to providing information on
the company’s recently introduced CBD Formulation, RespRx, for the treatment of
Chronic Obstructive Pulmonary Disease (COPD) affecting 65 million people
worldwide.
KALY introduced the new CBD
Formulation earlier this week after making a patent
application and trademark registration for the formulation. The website will be continually updated with
information about the patent and application trademark progress and the ongoing
RespRx medical trials and developments as the company advances toward FDA
approval.
In the fourth quarter of last year, 2018,
KALY acquired NCM Biotech (NCMB). NCMB owns and operates a U.S. Patent for
cannabis extraction process. With the
acquisition of NCMB, KALY is now primarily in the business of developing
biopharmaceutical formulations from cannabis extractions for the treatment of
various diseases. KALY now has over four
years of research and development behind cannabis extract formulations
targeting the treatment of Chronic Obstructive Pulmonary Disease (COPD), Cancer
Pain Management, Type 2 Diabetes and Epilepsy.
KALY has implemented a long-term
sustainable overall business strategy.
KALY is not just relying on its biopharmaceutical development strategy
alone to insure the company’s long-term success. KALY, through partnership and independently,
has also introduced to market a number of CBD infused consumer food products
and a new CBD extraction service for hemp farming operations.
The revenue realized in the first six
months of 2019 comes primarily from KALY’s various CBD infusion offerings. KALY realized $165,000 in revenue in the
first six months of 2019. The revenue
results from the company’s cannabis business shift in the fourth quarter of
last year. In the first six months of
2018, KALY reported only $46,000 in sales.
The introduction of KALY’s new cannabis business has seen the company’s
revenue grow over 250% in the first six months of 2019 compared to the first
six months of 2018. KALY also realized
$70,000 in operating net income in the first six months of 2019. KALY reported only nominal operating net
income in the first six months of 2018.
Investor ideas reminds all listeners to read our disclaimers and
disclosures on the
Investorideas.com website and this podcast is not an endorsement
to buy products or services or securities. Investors are reminded all
investment involves risk and possible loss of investment
Subscribe to the new cannabis podcast series:
Investorideas.com podcasts are also available
on iTunes, Spotify, Google Play Music,
Stitcher, Spreaker, YouTube via
Spreaker, iHeartradio and Tunein.
Potcasts is now a certified word mark Trademark
on the blockchain through Cognate, Inc. CM Certification-Registration Number:
10468217708
About Investorideas.com - News that Inspires Big Investing Ideas
Investorideas.com is a recognized news
source publishing third party news and press releases plus we create original
financial content. Learn about investing in stocks and sector trends
from Investorideas.com with our news alerts , articles , podcasts and videos talking about cannabis, crypto,
technology including AI and IoT ,
mining ,sports biotech, water, renewable energy and more . Investorideas.com
original branded content includes the daily Crypto Corner and Podcast, Play
by Play sports and stock news column, Investor Ideas #Potcasts #Cannabis News
and Stocks on the Move podcast and column,
Cleantech and Climate Change Podcast and
the AI
Eye Podcast and column covering developments in
AI.
Disclaimer/Disclosure: Investorideas.com is a
digital publisher of third party sourced news, articles and equity research as
well as creates original content, including video, interviews and articles.
Original content created by investorideas is protected by copyright laws other
than syndication rights. Our site does not make recommendations for purchases
or sale of stocks, services or products. Nothing on our sites should be
construed as an offer or solicitation to buy or sell products or securities.
All investing involves risk and possible losses. This site is currently
compensated for news publication and distribution, social media and marketing,
content creation and more. Disclosure is posted for each compensated news
release, content published /created if required but otherwise the news was not
compensated for and was published for the sole interest of our readers and
followers. Contact management and IR of each company directly regarding
specific questions.
More disclaimer info: https://www.investorideas.com/About/Disclaimer.asp Learn
more about publishing your news release and our other news services on the
Investorideas.com newswire https://www.investorideas.com/News-Upload/ and
tickertagstocknews.com
Global investors must adhere to regulations of each
country. Please read Investorideas.com privacy policy: https://www.investorideas.com/About/Private_Policy.asp
Investor Ideas does not condone the use of cannabis except where
permissible by law. Our site does not possess, distribute, or sell cannabis
products.
Follow us on Social Media
Contact Investorideas.com
800-665-0411
Subscribe to:
Posts (Atom)
-
Investorideas.com - Cannabis Stock News: TransCanna (CSE: TCAN) Product Ranks in Leafly's Top Cannabis Strains List
-
Investorideas.com - CBD Stock News: InnoCan Pharma (CSE: INNO) Announces the Successful Completion of an Independent Clinical Study Demonstr...
-
New #Cannabis Stocks Added to Investor Ideas; (TSX: $FAF.V) (CSE: $STIL.C) (CSE: $ORCD.C) (CSE: $VREO.C) (CSE: $PUMP.C) (OTC: $NUGL) ...